Literature DB >> 6502649

Hereditary coproporphyria: incidence in a large English family.

J Andrews, H Erdjument, D C Nicholson.   

Abstract

In a family inheriting the hereditary coproporphyria (HCP) gene, where 414 descendants have been traced through six generations and 135 members screened for faecal porphyrins, 27 subjects were found to have inherited the gene as well as the proband. Seven (six female and one male) in retrospect had probably previously suffered from a clinical attack of porphyria. Enzymological studies were carried out on 15 members and two unaffected parents and these results in general agreed with the faecal coproporphyrin readings. Symptomatic illness is low in HCP and is almost always precipitated by drugs known to have an adverse effect on the condition. If the gene is inherited, an attack can occur at any time between puberty and old age, such as in the proband at 84 years. We have detected abnormal faecal coproporphyrin levels in members of this pedigree as young as 12 years and as old as 87 years. Recommendations are given concerning the necessity of tracing relatives who may have inherited the gene and arranging for their biochemical screening and genetic counseling if indicated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502649      PMCID: PMC1049314          DOI: 10.1136/jmg.21.5.341

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  14 in total

1.  Hereditary coproporphyria.

Authors:  H BERGER; A GOLDBERG
Journal:  Br Med J       Date:  1955-07-09

2.  Hereditary coproporphyria. Study of a Swedish family.

Authors:  B Haeger-Aronsen; G Stathers; G Swahn
Journal:  Ann Intern Med       Date:  1968-08       Impact factor: 25.391

3.  A study of faecal porphyrin levels in a large family.

Authors:  A L Cochrane; A Goldberg
Journal:  Ann Hum Genet       Date:  1968-10       Impact factor: 1.670

4.  Coproporphyria.

Authors:  P Lamb; G Dean; S Kramer
Journal:  S Afr Med J       Date:  1969-02-08

5.  A geriatrician's view.

Authors:  J Andrews
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

6.  Decreased lymphocyte coproporphyrinogen III oxidase activity in hereditary coproporphyria.

Authors:  B Grandchamp; Y Nordmann
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

7.  The primary enzyme defect in hereditary coproporphyria.

Authors:  G H Elder; J O Evans; N Thomas
Journal:  Lancet       Date:  1976-12-04       Impact factor: 79.321

Review 8.  International review of drugs in acute porphyria--1980.

Authors:  M R Moore
Journal:  Int J Biochem       Date:  1980

9.  A radiochemical method for the measurement of coproporphyrinogen oxidase and the utilization of substrates other than coproporphyrinogen III by the enzyme from rat liver.

Authors:  G H Elder; J O Evans
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

10.  Reduced induction of drug metabolism in the elderly.

Authors:  S A Salem; P Rajjayabun; A M Shepherd; I H Stevenson
Journal:  Age Ageing       Date:  1978-05       Impact factor: 10.668

View more
  3 in total

1.  Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria.

Authors:  J Lamoril; H Puy; S D Whatley; C Martin; J R Woolf; V Da Silva; J C Deybach; G H Elder
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

2.  Encephalopathy due to hyponatraemia in acute intermittent porphyria.

Authors:  J Andrews
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

Review 3.  Environmental chemical exposures and disturbances of heme synthesis.

Authors:  W E Daniell; H L Stockbridge; R F Labbe; J S Woods; K E Anderson; D M Bissell; J R Bloomer; R D Ellefson; M R Moore; C A Pierach; W E Schreiber; A Tefferi; G M Franklin
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.